Aryl-capped lysine-dehydroamino acid dipeptide supergelators as potential drug release systems
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://hdl.handle.net/1822/80373 |
Resumo: | Employing amino acids and peptides as molecular building blocks provides unique opportunities for generating supramolecular hydrogels, owing to their inherent biological origin, bioactivity, biocompatibility, and biodegradability. However, they can suffer from proteolytic degradation. Short peptides (<8 amino acids) attached to an aromatic capping group are particularly attractive alternatives for minimalistic low molecular weight hydrogelators. Peptides with low critical gelation concentrations (CGCs) are especially desirable, as the low weight percentage required for gelation makes them more cost-effective and reduces toxicity. In this work, three dehydrodipeptides were studied for their self-assembly properties. The results showed that all three dehydrodipeptides can form self-standing hydrogels with very low critical gelation concentrations (0.050.20 wt%) using a pH trigger. Hydrogels of all three dehydrodipeptides were characterised by scanning tunnelling emission microscopy (STEM), rheology, fluorescence spectroscopy, and circular dichroism (CD) spectroscopy. Molecular modelling was performed to probe the structural patterns and interactions. The cytotoxicity of the new compounds was tested using human keratinocytes (HaCaT cell line). In general, the results suggest that all three compounds are non-cytotoxic, although one of the peptides shows a small impact on cell viability. In sustained release assays, the effect of the charge of the model drug compounds on the rate of cargo release from the hydrogel network was evaluated. The hydrogels provide a sustained release of methyl orange (anionic) and ciprofloxacin (neutral), while methylene blue (cationic) was retained by the network. |
id |
RCAP_376a8958d26fb76755c4da9cf0f1d0d6 |
---|---|
oai_identifier_str |
oai:repositorium.sdum.uminho.pt:1822/80373 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Aryl-capped lysine-dehydroamino acid dipeptide supergelators as potential drug release systemscritical gelation concentrationdehydrodipeptidesdrug delivery systemslysineself-assemblysupramolecular hydrogelsScience & TechnologyEmploying amino acids and peptides as molecular building blocks provides unique opportunities for generating supramolecular hydrogels, owing to their inherent biological origin, bioactivity, biocompatibility, and biodegradability. However, they can suffer from proteolytic degradation. Short peptides (<8 amino acids) attached to an aromatic capping group are particularly attractive alternatives for minimalistic low molecular weight hydrogelators. Peptides with low critical gelation concentrations (CGCs) are especially desirable, as the low weight percentage required for gelation makes them more cost-effective and reduces toxicity. In this work, three dehydrodipeptides were studied for their self-assembly properties. The results showed that all three dehydrodipeptides can form self-standing hydrogels with very low critical gelation concentrations (0.050.20 wt%) using a pH trigger. Hydrogels of all three dehydrodipeptides were characterised by scanning tunnelling emission microscopy (STEM), rheology, fluorescence spectroscopy, and circular dichroism (CD) spectroscopy. Molecular modelling was performed to probe the structural patterns and interactions. The cytotoxicity of the new compounds was tested using human keratinocytes (HaCaT cell line). In general, the results suggest that all three compounds are non-cytotoxic, although one of the peptides shows a small impact on cell viability. In sustained release assays, the effect of the charge of the model drug compounds on the rate of cargo release from the hydrogel network was evaluated. The hydrogels provide a sustained release of methyl orange (anionic) and ciprofloxacin (neutral), while methylene blue (cationic) was retained by the network.This work was supported by the Portuguese Foundation for Science and Technology (FCT) in the framework of the Strategic Funding of CQUM (UID/QUI/00686/2019), IPC (UIDP/CTM/05256/2020 and UIDB/05256/2020) and REQUIMTE/LAQV (UIDB/50006/2020). L.H. acknowledges grant CEECINST/00156/2018. FCT, FEDER, PORTUGAL2020 and COMPETE2020 are also acknowl edged for funding under research project PTDC/QUI-QOR/29015/2017 (POCI-01-0145-FEDER 029015). TGC thanks FCT under the scope of the strategic funding of UIDB/04469/2020 unit, and LABBELS—Associate Laboratory in Biotechnology, Bioengineering and Microelectromechanical Systems, LA/P/0029/2020.info:eu-repo/semantics/publishedVersionMDPIUniversidade do MinhoOliveira, Carlos B. P.Pereira, Renato B.Pereira, David M.Hilliou, L.Castro, Tarsila GabrielMartins, J. A. R.Jervis, Peter JohnFerreira, Paula M. T.2022-10-052022-10-05T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/1822/80373engOliveira, C.B.P.; Pereira, R.B.; Pereira, D.M.; Hilliou, L.; Castro, T.G.; Martins, J.A.; Jervis, P.J.; Ferreira, P.M.T. Aryl-Capped Lysine-Dehydroamino Acid Dipeptide Supergelators as Potential Drug Release Systems. Int. J. Mol. Sci. 2022, 23, 11811. https://doi.org/10.3390/ijms2319118111424-67831661-65961422-006710.3390/ijms23191181136233112https://www.mdpi.com/1422-0067/23/19/11811info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T12:10:01Zoai:repositorium.sdum.uminho.pt:1822/80373Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T19:01:34.038412Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Aryl-capped lysine-dehydroamino acid dipeptide supergelators as potential drug release systems |
title |
Aryl-capped lysine-dehydroamino acid dipeptide supergelators as potential drug release systems |
spellingShingle |
Aryl-capped lysine-dehydroamino acid dipeptide supergelators as potential drug release systems Oliveira, Carlos B. P. critical gelation concentration dehydrodipeptides drug delivery systems lysine self-assembly supramolecular hydrogels Science & Technology |
title_short |
Aryl-capped lysine-dehydroamino acid dipeptide supergelators as potential drug release systems |
title_full |
Aryl-capped lysine-dehydroamino acid dipeptide supergelators as potential drug release systems |
title_fullStr |
Aryl-capped lysine-dehydroamino acid dipeptide supergelators as potential drug release systems |
title_full_unstemmed |
Aryl-capped lysine-dehydroamino acid dipeptide supergelators as potential drug release systems |
title_sort |
Aryl-capped lysine-dehydroamino acid dipeptide supergelators as potential drug release systems |
author |
Oliveira, Carlos B. P. |
author_facet |
Oliveira, Carlos B. P. Pereira, Renato B. Pereira, David M. Hilliou, L. Castro, Tarsila Gabriel Martins, J. A. R. Jervis, Peter John Ferreira, Paula M. T. |
author_role |
author |
author2 |
Pereira, Renato B. Pereira, David M. Hilliou, L. Castro, Tarsila Gabriel Martins, J. A. R. Jervis, Peter John Ferreira, Paula M. T. |
author2_role |
author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade do Minho |
dc.contributor.author.fl_str_mv |
Oliveira, Carlos B. P. Pereira, Renato B. Pereira, David M. Hilliou, L. Castro, Tarsila Gabriel Martins, J. A. R. Jervis, Peter John Ferreira, Paula M. T. |
dc.subject.por.fl_str_mv |
critical gelation concentration dehydrodipeptides drug delivery systems lysine self-assembly supramolecular hydrogels Science & Technology |
topic |
critical gelation concentration dehydrodipeptides drug delivery systems lysine self-assembly supramolecular hydrogels Science & Technology |
description |
Employing amino acids and peptides as molecular building blocks provides unique opportunities for generating supramolecular hydrogels, owing to their inherent biological origin, bioactivity, biocompatibility, and biodegradability. However, they can suffer from proteolytic degradation. Short peptides (<8 amino acids) attached to an aromatic capping group are particularly attractive alternatives for minimalistic low molecular weight hydrogelators. Peptides with low critical gelation concentrations (CGCs) are especially desirable, as the low weight percentage required for gelation makes them more cost-effective and reduces toxicity. In this work, three dehydrodipeptides were studied for their self-assembly properties. The results showed that all three dehydrodipeptides can form self-standing hydrogels with very low critical gelation concentrations (0.050.20 wt%) using a pH trigger. Hydrogels of all three dehydrodipeptides were characterised by scanning tunnelling emission microscopy (STEM), rheology, fluorescence spectroscopy, and circular dichroism (CD) spectroscopy. Molecular modelling was performed to probe the structural patterns and interactions. The cytotoxicity of the new compounds was tested using human keratinocytes (HaCaT cell line). In general, the results suggest that all three compounds are non-cytotoxic, although one of the peptides shows a small impact on cell viability. In sustained release assays, the effect of the charge of the model drug compounds on the rate of cargo release from the hydrogel network was evaluated. The hydrogels provide a sustained release of methyl orange (anionic) and ciprofloxacin (neutral), while methylene blue (cationic) was retained by the network. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-10-05 2022-10-05T00:00:00Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/1822/80373 |
url |
https://hdl.handle.net/1822/80373 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Oliveira, C.B.P.; Pereira, R.B.; Pereira, D.M.; Hilliou, L.; Castro, T.G.; Martins, J.A.; Jervis, P.J.; Ferreira, P.M.T. Aryl-Capped Lysine-Dehydroamino Acid Dipeptide Supergelators as Potential Drug Release Systems. Int. J. Mol. Sci. 2022, 23, 11811. https://doi.org/10.3390/ijms231911811 1424-6783 1661-6596 1422-0067 10.3390/ijms231911811 36233112 https://www.mdpi.com/1422-0067/23/19/11811 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
MDPI |
publisher.none.fl_str_mv |
MDPI |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799132414394499072 |